NASDAQ : CRNX

Crinetics Pharmaceuticals, Inc.

$83.9 USD

$0.19 (0.23%)

Volume
3.29M
Average Volume
3.3M
Market Capitalization
$8.88B
P/E Ratio
-16.32
Dividend Yield
0.00%
Price Target
$85.00
Year High
$84.00
Year Low
$25.83
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$18.60

CRNX Estimated and Actual Revenue by Quarter

CRNX Estimated and Actual EPS by Quarter

CRNX Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 7 -63.27M -47.24M -56.28M -63.27M -47.24M -56.28M
2027-09-30 4 -51.87M -38.73M -46.14M -51.87M -38.73M -46.14M
2027-06-30 6 -42.35M -31.62M -37.67M -42.35M -31.62M -37.67M
2027-03-31 4 -30.6M -22.85M -27.22M -30.6M -22.85M -27.22M
2026-12-31 7 -27.15M -20.27M -24.15M -27.15M -20.27M -24.15M
2026-09-30 8 -21.06M -16.37M -18.97M -21.06M -16.37M -18.97M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 7 -111.59M -76.02M -96.08M 1.58B 2.11B 1.88B
2027-09-30 4 -119.98M -81.74M -103.3M 1.29B 1.73B 1.54B
2027-06-30 6 -124.69M -84.95M -107.36M 1.06B 1.41B 1.26B
2027-03-31 4 -131.42M -89.53M -113.15M 763.28M 1.02B 909.26M
2026-12-31 7 -141.11M -96.14M -121.5M 677.18M 906.88M 806.69M
2026-09-30 8 -136.88M -97.04M -123.6M 546.9M 703.62M 633.72M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 7 47.24M 63.27M 56.28M 3 -1.07194 -0.7303 -0.92293
2027-09-30 4 38.73M 51.87M 46.14M 4 -1.15254 -0.78521 -0.99232
2027-06-30 6 31.62M 42.35M 37.67M 3 -1.19779 -0.81604 -1.03128
2027-03-31 4 22.85M 30.6M 27.22M 3 -1.26245 -0.86009 -1.08695
2026-12-31 7 20.27M 27.15M 24.15M 7 -1.35557 -0.92354 -1.16713
2026-09-30 8 16.37M 21.06M 18.97M 9 -1.31489 -0.9322 -1.18733